Stock Market announcementBergen, Norway -October 20, 2020 : The Norwegian listed companyLifecare AS (LIFE-ME) has a 25% ownership in the German companyDigital Diagnostics AG , which has developed an accurate and reliable rapid test for Covid-19.Bionovate Technologies Corp. (BIIO), a swiss based company traded at Nasdaq OTC Foreign, has announced a Share Exchange Agreement betweenEvergreen Solutions Ltd. andHuman Data AG to theUnited States Securities and Exchange Commission . According to the announcementHuman Data AG will, in exchange for 25% of the shares inDigital Diagnostics AG , receive 54,270,000 shares inBionovate Technologies Corp. fromEvergreen Solutions Ltd. Shares inBionovate Technologies Corp. was traded at a price per shareUSD 4 onOctober 19th, 2020 , valuating the transaction of 25% ofDigital Diagnostics AG toUSD 217,080,000 . In the opinion of Lifecare, the transaction is subject for board approval inDigital Diagnostics AG .Digital Diagnostics AG has not been notified of the transaction, and the transaction is not registered in theGerman Trade Register . Lifecare (LIFE-ME) is aBergen -based technology company developing a miniature sensor for correct and continuous monitoring of diabetics' blood sugar. Its patented technology is also used as a central component in a rapid test for Covid-19 and as a measurement unit for reading out different biomarkers. For more information, please contact:Joacim Holter CEO, Lifecare joacim.holter@lifecare.no +47 40 05 90 40
Click here for more information
© Oslo Bors ASA, source